Registering for this site allows you to access your order status and history. Just fill in the fields below, and we’ll get a new account set up for you in no time. We will only ask you for information necessary to make the purchase process faster and easier.
Create an AccountCELLULAR FUNDAMENTALS PROTOCOL™
The Cellular Fundamentals Protocol™ is a research framework built around NAD+, MOTS-c, KPV, and AOD9604 — four compounds frequently examined in scientific literature relating to cellular energy systems, mitochondrial signalling, inflammatory pathway models, and metabolic regulation research. Supplied strictly for in-vitro laboratory investigation.
This protocol maps to four foundational biological domains commonly studied in experimental systems: NAD+ as a redox coenzyme and signalling substrate (sirtuins, PARPs, salvage pathway biology); MOTS-c as a mitochondrial-derived metabolic signalling peptide (AMPK-related research); KPV as a minimal inflammation-modulating sequence (NF-κB signalling models); and AOD9604 as a modified hGH fragment studied in adipose signalling research.
• REDOX & ENZYME SIGNALLING
• MITOCHONDRIAL STRESS ADAPTATION
• NF-κB PATHWAY RESEARCH
• ADIPOSE SIGNALLING MODELS
NAD+
NAD+ functions as a foundational coenzyme in redox reactions and serves as a substrate for NAD+-consuming enzymes including sirtuins and PARPs. Research frequently examines its role within DNA repair signalling, transcriptional regulation, and salvage pathway dynamics in controlled laboratory models.
Established cellular biochemistry; translational context model-dependent.
MOTS-c
MOTS-c is investigated as a mitochondrial-encoded peptide associated with metabolic stress signalling pathways. Literature often references AMPK-related mechanisms and nuclear transcriptional responses within experimental systems examining mitochondrial adaptation.
Strong preclinical foundation; human research investigational.
KPV
KPV (Lys-Pro-Val) is studied as a minimal sequence derived from α-MSH and examined in experimental models focused on inflammatory signalling modulation, particularly within epithelial and immune cellular systems.
Preclinical emphasis; mechanistic research focus.
AOD9604
AOD9604 is a modified C-terminal fragment associated with human growth hormone research. Preclinical literature explores lipid metabolism signalling and β-adrenergic pathway context. Historical human development programmes reported mixed efficacy outcomes.
Robust preclinical exploration; mixed historical clinical findings.
The Cellular Fundamentals Protocol™ is presented for scientific context only. Mechanisms described reflect experimental literature and should not be interpreted as clinical claims. Axiom supplies all compounds strictly for in-vitro laboratory research.
NOT FOR HUMAN CONSUMPTION
NOT FOR MEDICAL USE
SUPPLIED FOR IN-VITRO RESEARCH
COMPLIANCE ENFORCED
Precision in supply. Discipline in research.
Defined standards without compromise.
VIEW RESEARCH COMPOUNDS